올리패스 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 유명희, was filed 07 Apr 2026.
올리패스: what insiders have been doing
올리패스, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). In the past year (2 November 2025 to 2 November 2026), 5 filings came from 3 insiders.
Every open-market trade in the period is a purchase: 5 purchases, from 3 insiders, and not a single sale. No amount is published for 5 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 1 board member and 1 chief executive.
The latest purchase dates back some time: it was published 217 days ago, on 7 April 2026.
With 5 filings in twelve months, the company is quieter than the median of 7 filings across the 2,655 companies we follow on the same exchange. Since 2021, the database holds 83 purchases and 1 sale by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +0.0%Entry ₩1,651 · Close 30 Oct 2026 ₩1,651
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 75,036 sharesShareKRXDART:20260407000694Canonical exit: 6 Jul 2026 (T+90)
- 210,000 sharesShareKRXDART:20251215000449Canonical exit: 15 Mar 2026 (T+90)
- 1,478,000 sharesKRXDART:20251210000434Canonical exit: 9 Mar 2026 (T+90)
- 654,000 sharesShareKRXDART:20251210000483Canonical exit: 9 Mar 2026 (T+90)
- 654,000 sharesShareKRXDART:20251210000501Canonical exit: 10 Mar 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 266,204 sharesKRXDART:20241023000140Canonical exit: 19 Dec 2024 (T+90)
- ●Executives0DART
- 197,764 sharesKRXDART:20240626000231
- 4,748,983 sharesKRXDART:20240625000155Canonical exit: 17 Sept 2024 (T+90)
- 2,273,636 sharesKRXDART:20240610000368Canonical exit: 27 Aug 2024 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ShareKRXDART:20230905000289Canonical exit: 27 Nov 2023 (T+90)
- 2,273,636 sharesKRXDART:20230905000290Canonical exit: 27 Nov 2023 (T+90)
- ShareKRXDART:20230727000519Canonical exit: 5 Sept 2023 (T+90)
- 2,273,636 sharesKRXDART:20230727000527Canonical exit: 10 Sept 2023 (T+90)
- 2,273,636 sharesKRXDART:20230707000472Canonical exit: 3 Oct 2023 (T+90)
- 2,273,636 sharesKRXDART:20230705000312Canonical exit: 28 Sept 2023 (T+90)
- ShareKRXDART:20230626000342Canonical exit: 17 Sept 2023 (T+90)
- 2,273,636 sharesKRXDART:20230626000343Canonical exit: 17 Sept 2023 (T+90)
25 of 98 declarations
About 올리패스
OliPass is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative treatments and therapeutic solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
